GS
Govindan Subramanian
Architect Therapeutics, Gossamer Bio (United States), University of Hyderabad, Zoetis Research and Development
0000-0002-6040-0415
Employment
-
Architect Therapeutics Senior Director2023 - 2025
-
Gossamer Bio (United States) Senior Director2022 - 2023
-
Zoetis Research and Development Senior Principal Scientist2013 - 2022
-
University of Texas MD Anderson Cancer Center Institute Research Scientist2012 - 2013
-
Sanofi Principal Scientist2006 - 2011
-
Transtech Pharma Inc Associate Director2001 - 2006
-
ArQule Inc Senior Scientist2000 - 2001
Education
-
University of Hyderabad Ph. D.1990 - 1994
Projects & Funding
Projects & funding information is unavailable.
Publications (39)
- Monovalent cation binding to model systems and the macrocyclic depsipeptide, emodepside Save
- In Pursuit of an Allosteric Human Tropomyosin Kinase A (hTrkA) Inhibitor for Chronic Pain Save
- Synthetic inhibitor leads of human tropomyosin receptor kinase A (hTrkA) Save
- Connecting the conformational behavior of cyclic octadepsipeptides with their ionophoric property and membrane permeability Save
- Lead identification and characterization of hTrkA type 2 inhibitors Save
- Deciphering the Allosteric Binding Mechanism of the Human Tropomyosin Receptor Kinase A (hTrkA) Inhibitors Save
- In silico ligand‐based modeling of hBACE‐1 inhibitors Save
- Computational Modeling of β-Secretase 1 (BACE-1) Inhibitors Using Ligand Based Approaches Save
- Computational modeling and design of renin inhibitors Save
- Comprehending renin inhibitor’s binding affinity using structure-based approaches Save